Lung cancer is one of the leading causes of cancer-related deaths worldwide, with non-small cell lung cancer (NSCLC) accounting for approximately 85% of all cases. The discovery of specific genetic alterations in NSCLC has significantly improved the management and prognosis of patients with this disease. Among these genetic alterations, mutations in the ALK1 and ROS1 genes have been identified as critical drivers in a subset of NSCLC cases. Identifying patients with these mutations is crucial as it allows for the use of targeted therapies, which have shown remarkable efficacy. The FISH (Fluorescence In Situ Hybridization) NSCLC Non-Small Cell Lung Cancer ALK1 and ROS1 Test is a specialized diagnostic tool used to detect these genetic alterations. This article will delve into the symptoms of NSCLC linked to ALK1 and ROS1 mutations and provide detailed information about the FISH test, including its cost.
Symptoms of NSCLC Linked to ALK1 and ROS1 Mutations
NSCLC patients with ALK1 and ROS1 mutations often present with symptoms similar to those of other types of lung cancer. However, understanding these symptoms is vital for early detection and treatment. Common symptoms include:
- Persistent coughing, sometimes accompanied by blood
- Shortness of breath or difficulty breathing
- Chest pain
- Hoarseness
- Weight loss and loss of appetite
- Feeling tired or weak
- Recurrent infections such as bronchitis or pneumonia
It’s important to note that these symptoms can also be associated with other conditions. Therefore, individuals experiencing these symptoms should consult a healthcare provider for an accurate diagnosis.
The FISH NSCLC Non-Small Cell Lung Cancer ALK1 and ROS1 Test
The FISH NSCLC Non-Small Cell Lung Cancer ALK1 and ROS1 Test is a cutting-edge diagnostic tool designed to detect rearrangements in the ALK1 and ROS1 genes in tumor tissue. This test is crucial for identifying patients eligible for targeted therapy, which can significantly improve treatment outcomes. The test utilizes fluorescent probes to visualize the presence of ALK1 and ROS1 gene rearrangements under a microscope, providing a reliable and accurate diagnosis.
Benefits of the FISH Test
There are several benefits to using the FISH test for detecting ALK1 and ROS1 gene mutations in NSCLC, including:
- High sensitivity and specificity for identifying gene rearrangements
- Enabling personalized treatment plans that significantly improve patient outcomes
- Quick turnaround time, allowing for timely initiation of targeted therapies
- Non-invasive, as it requires only a small tissue sample from the tumor
Test Cost
The cost of the FISH NSCLC Non-Small Cell Lung Cancer ALK1 and ROS1 Test is 2810 AED. This investment in accurate diagnosis is crucial for tailoring the most effective treatment plans for patients, ultimately improving their quality of life and survival rates. For more detailed information about the test, including how to order it, please visit DNA Labs UAE.
Conclusion
Early and accurate diagnosis of NSCLC and the identification of specific genetic mutations such as ALK1 and ROS1 are paramount in the management of lung cancer. The FISH NSCLC Non-Small Cell Lung Cancer ALK1 and ROS1 Test provides a reliable means of detecting these mutations, enabling the use of targeted therapies that have been shown to significantly improve patient outcomes. Given the symptoms associated with NSCLC, individuals experiencing these symptoms should seek medical advice promptly. With the test’s cost of 2810 AED, DNA Labs UAE is committed to offering precise diagnostic solutions that pave the way for personalized and effective cancer treatment.
